THINK BEYOND LDL-C TARGETS WITH PROVEN CV RISK REDUCTION

Think beyond statins + ezetimibe with NUSTENDI®: One tablet combining two complementary LDL-C lowering agents²

Concomitant use with simvastatin >40 mg daily is contraindicated; please refer to the SmPC for more information.²

For patients taking a bile acid sequestrant concomitantly, dosing of NUSTENDI® should occur either at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant.²

Liver function tests should be performed at initiation of NUSTENDI® therapy and treatment with NUSTENDI® should be discontinued if an increase in transaminases >3x ULN persists.²

Please refer to the NUSTENDI® SmPC prior to prescribing.²

Think beyond statins with NILEMDO®¹

Concomitant use with simvastatin >40 mg daily is contraindicated; please refer to the SmPC for more information.¹

Liver function tests should be performed at initiation of NILEMDO® therapy and treatment with NILEMDO® should be discontinued if an increase in transaminases >3x ULN persists.¹

Please refer to the NILEMDO® SmPC prior to prescribing.¹